Skip to main content

Advertisement

SpringerLink
Log in

Leukemia-derived dendritic cells in acute myeloid leukemia exhibit potent migratory capacity

  • Correspondence
  • Published:
Leukemia Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1
Figure 2

References

  1. Westers TM, Stam AG, Scheper RJ, Regelink JC, Nieuwint AW, Schuurhuis GJ et al. Rapid generation of antigen-presenting cells from leukaemic blasts in acute myeloid leukaemia. Cancer Immunol Immunother 2003; 52: 17–27.

    Article  CAS  Google Scholar 

  2. Mailliard RB, Wankowicz-Kalinska A, Cai Q, Wesa A, Hilkens CM, Kapsenberg ML et al. alpha-type-1 polarized dendritic cells: a novel immunization tool with optimized CTL-inducing activity. Cancer Res 2004; 64: 5934–5937.

    Article  CAS  Google Scholar 

  3. Scandella E, Men Y, Gillessen S, Forster R, Groettrup M . Prostaglandin E2 is a key factor for CCR7 surface expression and migration of monocyte-derived dendritic cells. Blood 2002; 100: 1354–1361.

    Article  CAS  Google Scholar 

  4. Cignetti A, Vallario A, Roato I, Circosta P, Allione B, Casorzo L et al. Leukemia-derived immature dendritic cells differentiate into functionally competent mature dendritic cells that efficiently stimulate T cell responses. J Immunol 2004; 173: 2855–2865.

    Article  CAS  Google Scholar 

  5. Camporeale A, Boni A, Iezzi G, Degl’Innocenti E, Grioni M, Mondino A et al. Critical impact of the kinetics of dendritic cells activation on the in vivo induction of tumor-specific T lymphocytes. Cancer Res 2003; 63: 3688–3694.

    CAS  PubMed  Google Scholar 

  6. Ishii K, Kurita-Taniguchi M, Aoki M, Kimura T, kashiwazaki Y, Matsumoto M et al. Gene-inducing program of human dendritic cells in response to BCG cell-wall skeleton (CWS), which reflects adjuvancy required for tumor immunotherapy. Immunol Lett 2005; 98: 280–290.

    Article  CAS  Google Scholar 

  7. Mohty M, Isnardon D, Blaise D, Mozziconacci MJ, Lafage-Pochitaloff M, Briere F et al. Identification of precursors of leukemic dendritic cells differentiated from patients with acute myeloid leukemia. Leukemia 2002; 16: 2267–2274.

    Article  CAS  Google Scholar 

  8. Eisendle K, Lang A, Eibl B, Nachbaur D, Glassl H, Fiegl M et al. Phenotypic and functional deficiencies of leukaemic dendritic cells from patients with chronic myeloid leukaemia. Br J Haematol 2003; 120: 63–73.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Hematology, VU University Medical Center, Amsterdam, The Netherlands

    T M Westers, I Houtenbos, N C L Snoijs, A A van de Loosdrecht & G J Ossenkoppele

Authors
  1. T M Westers
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. I Houtenbos
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. N C L Snoijs
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A A van de Loosdrecht
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. G J Ossenkoppele
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to T M Westers.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Westers, T., Houtenbos, I., Snoijs, N. et al. Leukemia-derived dendritic cells in acute myeloid leukemia exhibit potent migratory capacity. Leukemia 19, 1270–1272 (2005). https://doi.org/10.1038/sj.leu.2403794

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2403794

  • Springer Nature Limited

This article is cited by

Search

Navigation